SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,752,000 | +1.0% | 31,048 | +11.0% | 0.00% | 0.0% |
Q4 2021 | $1,734,000 | -1.5% | 27,974 | +0.8% | 0.00% | 0.0% |
Q3 2021 | $1,761,000 | -22.1% | 27,754 | +1.2% | 0.00% | 0.0% |
Q2 2021 | $2,260,000 | +10.7% | 27,425 | -1.2% | 0.00% | 0.0% |
Q1 2021 | $2,041,000 | +4.6% | 27,749 | +3.1% | 0.00% | 0.0% |
Q4 2020 | $1,951,000 | +71.7% | 26,903 | +12.9% | 0.00% | 0.0% |
Q3 2020 | $1,136,000 | +29.8% | 23,835 | +14.4% | 0.00% | 0.0% |
Q2 2020 | $875,000 | +92.7% | 20,831 | +24.0% | 0.00% | – |
Q1 2020 | $454,000 | -27.2% | 16,799 | +3.7% | 0.00% | – |
Q4 2019 | $624,000 | -28.9% | 16,203 | -60.0% | 0.00% | -100.0% |
Q3 2019 | $878,000 | – | 40,514 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |